CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain
Adeno-associated viral (AAV) vectors are attractive tools for central nervous system (CNS) gene therapy because some vectors can cross the blood-brain barrier (BBB), allowing them to be used as minimally invasive treatments. A novel AAV vector recently evolved in vivo, AAV-PHP.eB, has been reported...
Main Authors: | Sophie N. Mathiesen, Jasmine L. Lock, Lucia Schoderboeck, Wickliffe C. Abraham, Stephanie M. Hughes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120302151 |
Similar Items
-
AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice
by: Chadderton, N., et al.
Published: (2022) -
Thermal Stability as a Determinant of AAV Serotype Identity
by: Antonette Bennett, et al.
Published: (2017-09-01) -
Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting
by: Livia S. Carvalho, et al.
Published: (2017-09-01) -
Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia
by: Francis J. May, et al.
Published: (2021-06-01) -
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
by: Pasqualina Colella, et al.
Published: (2018-03-01)